This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred More than three decades after a diagnosis of ...

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

Diabetic foot ulcer (DFU) is one of the most serious complications of diabetes and a major cause of lower-limb amputation.

Diabetes frequently leads to a combination of peripheral neuropathy, vascular insufficiency and infection in the lower limbs, culminating in ulceration and tissue loss. Amputation levels range from ...

Singapore, 7 May 2026 – Personalised risk-based monitoring may soon be the norm for patients with diabetes at high-risk of lower extremity amputation (LEA). Jointly developed by Singapore General ...

Diabetic foot ulcers arise from a convergence of peripheral neuropathy, microvascular and macrovascular disease, and impaired wound healing, posing a major threat to limb preservation. Effective ...

Diabetic ulcers, which occur in patients with diabetes, are dangerous complications that can lead to amputation if the treatment window is missed. A research team has developed a wireless, ...

The event brought together leading Irish and international experts to highlight the prevalence of diabetic foot disease in ...

Risk of recurrent major adverse limb events was lower in diabetes patients taking GLP-1 agents compared with DPP-4 inhibitors. Reduction of limb events was most significant for major amputations, ...

GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help ...